<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Expression levels of the <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> receptors (RAR-alpha, RAR-beta, and RAR-gamma) are significantly different in neoplastic tissues compared with non-neoplastic tissues for some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigated whether <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> receptor <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) expression levels are altered in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Relative <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of the RARs were quantified by using the ABI 7700 Sequence Detector (Taqman) system in Barrett's <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n = 15), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 6), <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 17), and matching <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues (n = 36) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: RAR-alpha expression was significantly increased, and RAR-gamma expression was significantly decreased, at higher stages in the Barrett's sequence </plain></SENT>
<SENT sid="4" pm="."><plain>There was almost complete loss of RAR-gamma expression (relative expression level &lt; or = 1) in a majority (70%) of the <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>There were significant differences in RAR-alpha and RAR-gamma expression in histopathologically <z:mpath ids='MPATH_458'>normal</z:mpath> tissues in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> versus patients without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RAR-beta expression levels were significantly elevated in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> versus <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues </plain></SENT>
<SENT sid="7" pm="."><plain>The RAR expression profile was similar for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> arising within the esophagus and for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> arising at the gastroesophageal junction </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: RAR <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels are significantly different in Barrett's tissues compared with <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues, and these levels are significantly different in Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues compared with nondysplastic tissues </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that RAR <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels may be useful biomarkers for this disease and that gastroesophageal junction <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> are genetically similar to esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>These results also suggest that a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> field is present in the esophagus in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and that genetic alterations can precede histopathologic alterations in this disease </plain></SENT>
</text></document>